Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The spatially resolved transcriptome signatures of glomeruli in chronic kidney disease
Geremy Clair, Hasmik Soloyan, Paolo Cravedi, Andrea Angeletti, Fadi Salem, Laith Al-Rabadi, Roger E. De Filippo, Stefano Da Sacco, Kevin V. Lemley, Sargis Sedrakyan, Laura Perin
Geremy Clair, Hasmik Soloyan, Paolo Cravedi, Andrea Angeletti, Fadi Salem, Laith Al-Rabadi, Roger E. De Filippo, Stefano Da Sacco, Kevin V. Lemley, Sargis Sedrakyan, Laura Perin
View: Text | PDF
Research Article Nephrology

The spatially resolved transcriptome signatures of glomeruli in chronic kidney disease

  • Text
  • PDF
Abstract

Here, we used digital spatial profiling (DSP) to describe the glomerular transcriptomic signatures that may characterize the complex molecular mechanisms underlying progressive kidney disease in Alport syndrome, focal segmental glomerulosclerosis, and membranous nephropathy. Our results revealed significant transcriptional heterogeneity among diseased glomeruli, and this analysis showed that histologically similar glomeruli manifested different transcriptional profiles. Using glomerular pathology scores to establish an axis of progression, we identified molecular pathways with progressively decreased expression in response to increasing pathology scores, including signal recognition particle–dependent cotranslational protein targeting to membrane and selenocysteine synthesis pathways. We also identified a distinct signature of upregulated and downregulated genes common to all the diseases investigated when compared with nondiseased tissue from nephrectomies. These analyses using DSP at the single-glomerulus level could help to increase insight into the pathophysiology of kidney disease and possibly the identification of biomarkers of disease progression in glomerulopathies.

Authors

Geremy Clair, Hasmik Soloyan, Paolo Cravedi, Andrea Angeletti, Fadi Salem, Laith Al-Rabadi, Roger E. De Filippo, Stefano Da Sacco, Kevin V. Lemley, Sargis Sedrakyan, Laura Perin

×

Figure 2

GeoMx digital spatial profiling platform workflow, selection of glomerular and tubular ROI, and quality control assessment.

Options: View larger image (or click on image) Download as PowerPoint
GeoMx digital spatial profiling platform workflow, selection of glomerul...
(A) Schematic illustration of the Nanostring GeoMx Digital Spatial Profiler workflow for interrogating multiple RNA analytes from a single paraffin-embedded tissue section. Analytes in the tissue section are conjugated with oligo tags via photocleavable linker, and glomerular ROIs are defined with the aid of morphology markers. Spatially mapped UV illumination allows oligo tags to be released from the analyte into a 96-well plate. The collected oligos are then subject to sequencing to obtain digital counts per ROI. (B) Select scans of glomerular and tubular ROI representative of AS (no. 1–3), FSGS (no. 4 and 5), and MN (no. 6 and 7) were immunostained for smooth muscle actin (SMA, green), Syto83 (nucleic acid stain, blue), CD3 (T cell marker, yellow), and Ki67 (marker of cellular proliferation, red) to guide the selection of ROIs. Individual glomeruli and tubules in the DSP were manually defined as individual geometric segments, with sizes ranging from 9,700 to 168,000 mm2. Scale bar: 100 μm. (C) Histogram showing the percentage of genes detected above LOQ relative to the percentage of glomerular segments analyzed. The number of genes detected per percentage of segments is depicted on top of each bar. (D) Dot plot depicting sequencing saturation (ranging between 75% and 95%) calculated over the areas of the glomerular ROIs. A, adult; Y, young. (E) Heatmap of TMM-normalized counts of transcripts, depicting the dynamic range of gene expression between glomerular and tubular ROI across all biopsies.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts